[MALAKOF] QoQ TTM Result on 31-Mar-2019 [#1]

Stock
[MALAKOF] MALAKOFF CORPORATION BERHAD
Announcement Date
27-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- 5.14%
YoY- 9.26%
Quarter Report
Latest QR
Upcoming QR
MALAKOF's Result
MALAKOF's Financial Summary
View:
Show?
TTM Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 7,422,272 7,568,439 7,622,079 7,751,341 7,348,230 7,254,336 7,163,092 2.39%
PBT 530,904 549,686 576,102 593,566 559,173 450,620 498,110 4.33%
Tax -156,218 -199,746 -239,735 -257,839 -235,693 -163,184 -222,449 -20.94%
NP 374,686 349,940 336,367 335,727 323,480 287,436 275,661 22.63%
-
NP to SH 320,153 299,231 288,235 288,532 274,433 232,674 213,351 30.97%
-
Tax Rate 29.42% 36.34% 41.61% 43.44% 42.15% 36.21% 44.66% -
Total Cost 7,047,586 7,218,499 7,285,712 7,415,614 7,024,750 6,966,900 6,887,431 1.54%
-
Net Worth 5,473,440 5,522,309 5,474,000 5,621,084 5,657,194 5,751,134 5,724,135 -2.93%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 320,110 291,430 291,430 275,802 275,802 288,626 288,626 7.12%
Div Payout % 99.99% 97.39% 101.11% 95.59% 100.50% 124.05% 135.28% -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 5,473,440 5,522,309 5,474,000 5,621,084 5,657,194 5,751,134 5,724,135 -2.93%
NOSH 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 0.00%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 5.05% 4.62% 4.41% 4.33% 4.40% 3.96% 3.85% -
ROE 5.85% 5.42% 5.27% 5.13% 4.85% 4.05% 3.73% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 151.88 154.87 155.95 158.58 149.38 147.58 145.16 3.05%
EPS 6.55 6.12 5.90 5.90 5.58 4.73 4.32 31.87%
DPS 6.55 5.94 5.94 5.60 5.60 5.80 5.80 8.42%
NAPS 1.12 1.13 1.12 1.15 1.15 1.17 1.16 -2.30%
Adjusted Per Share Value based on latest NOSH - 5,000,000
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 148.45 151.37 152.44 155.03 146.96 145.09 143.26 2.39%
EPS 6.40 5.98 5.76 5.77 5.49 4.65 4.27 30.87%
DPS 6.40 5.83 5.83 5.52 5.52 5.77 5.77 7.13%
NAPS 1.0947 1.1045 1.0948 1.1242 1.1314 1.1502 1.1448 -2.93%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 0.87 0.86 0.855 0.91 0.80 0.875 0.825 -
P/RPS 0.57 0.56 0.55 0.57 0.54 0.59 0.57 0.00%
P/EPS 13.28 14.05 14.50 15.42 14.34 18.49 19.08 -21.41%
EY 7.53 7.12 6.90 6.49 6.97 5.41 5.24 27.25%
DY 7.53 6.91 6.95 6.15 7.00 6.63 7.03 4.67%
P/NAPS 0.78 0.76 0.76 0.79 0.70 0.75 0.71 6.45%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 19/02/20 20/11/19 23/08/19 27/05/19 22/02/19 23/11/18 23/08/18 -
Price 0.90 0.885 0.875 0.80 0.895 0.865 1.03 -
P/RPS 0.59 0.57 0.56 0.50 0.60 0.59 0.71 -11.58%
P/EPS 13.74 14.45 14.84 13.55 16.04 18.27 23.82 -30.63%
EY 7.28 6.92 6.74 7.38 6.23 5.47 4.20 44.15%
DY 7.28 6.71 6.79 7.00 6.26 6.71 5.63 18.63%
P/NAPS 0.80 0.78 0.78 0.70 0.78 0.74 0.89 -6.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment